VISIUM TECHNOLOGIES INC (VISM) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed May 20, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VISM SEC filings page.
VISIUM TECHNOLOGIES INC (VISM) reported $0 in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Minimal reported revenue coexists with development spending and a liability-heavy balance sheet, making financing rather than scale the dominant mechanic.
Development-stage economics are visible in FY2021: R&D was$258K against revenue of$25K , so spending substantially exceeded commercial inflow. That mismatch is reinforced by operating cash flow of-$793K alongside positive financing cash flow of$888K , indicating that reported activity was funded outside operations.
Liabilities of
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
VISIUM TECHNOLOGIES INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
VISIUM TECHNOLOGIES INC generated $0 in revenue in Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Cash & Balance Sheet
VISIUM TECHNOLOGIES INC held $665 in cash as of Q3 2026; long-term debt is not reported for that period.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
None of these metrics is reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
VISM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| R&D Expenses | N/A | $0-100.0% | N/A | N/A | $0-100.0% | $75-99.6% | $0-100.0% | N/A |
| Interest Expense | N/A | $83K | N/A | N/A | $98K+31.4% | N/A | N/A | N/A |
| Income Tax | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| EPS (Basic) | N/A | N/A | N/A | N/A | N/A | N/A | $0.00+100.0% | N/A |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00+100.0% | $0.00 | $0.00 | $0.00 |
| Diluted Shares (Avg) | 463M | N/A | 397M+53.2% | N/A | 271M+150.6% | 252M | 259M | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, SG&A Expenses, Operating Income, EBITDA, Net Income.
VISM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13K-43.5% | $28K+315.1% | $9K+6.3% | $68K+700.0% | $22K-19.8% | $7K-86.0% | $8K-90.9% | $8K-15.3% |
| Current Assets | $13K | $28K+315.1% | $9K+6.3% | $68K+700.0% | N/A | $7K-86.0% | $8K-90.9% | $8K-15.3% |
| Cash & Equivalents | $665-97.0% | $24K+258.8% | $3K-63.1% | $60K+611.3% | $22K+169.3% | $7K-21.5% | $8K-73.5% | $8K-15.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $6.8M+28.9% | $6.4M+28.5% | $6.0M+28.4% | $5.9M+14.6% | $5.3M+7.5% | $5.0M+4.6% | $4.7M+0.1% | $5.2M+21.0% |
| Current Liabilities | $6.8M+28.9% | $6.4M+28.5% | $6.0M+28.4% | $5.9M+14.6% | $5.3M+7.5% | $5.0M+4.6% | $4.7M+0.1% | $5.2M+21.0% |
| Non-Current Liabilities | $1 | $1 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | -$6.8M-29.2% | -$6.4M-28.1% | -$6.0M-28.4% | -$5.8M-13.4% | -$5.3M-7.6% | -$5.0M-5.5% | -$4.7M-1.9% | -$5.1M-21.1% |
| Retained Earnings | -$65.6M-3.9% | -$65.0M-3.6% | -$64.5M-3.4% | -$64.1M-2.1% | -$63.2M-0.6% | -$62.8M-1.0% | -$62.4M-2.4% | -$62.7M-4.8% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
VISM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
VISM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$5.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| VISIUM TECHNOLOGIES INC VISM | FY2025 | $0 | N/A | N/A | $1.3M | — |
| OCULUS INC OVTZ | FY2025 | N/A | N/A | N/A | $2.6M | — |
| INNOVATIVE PYMNT SOLUTION IPSI | FY2025 | N/A | -$4.4M | N/A | $1.2M | — |
Where VISIUM TECHNOLOGIES INC Ranks
Frequently Asked Questions
What is VISIUM TECHNOLOGIES INC's annual revenue?
VISIUM TECHNOLOGIES INC (VISM) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What are VISIUM TECHNOLOGIES INC's total assets?
VISIUM TECHNOLOGIES INC (VISM) had $68K in total assets as of fiscal year 2025, including both current and long-term assets.
How much does VISIUM TECHNOLOGIES INC spend on research and development?
VISIUM TECHNOLOGIES INC (VISM) invested $325 in research and development during fiscal year 2025.
What is VISIUM TECHNOLOGIES INC's current ratio?
VISIUM TECHNOLOGIES INC (VISM) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is VISIUM TECHNOLOGIES INC's P/E ratio?
VISIUM TECHNOLOGIES INC (VISM) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $1.3M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is VISIUM TECHNOLOGIES INC's price-to-sales ratio?
VISIUM TECHNOLOGIES INC (VISM) has no price-to-sales ratio at the moment: revenue is not positive (FY2025). The market capitalization is $1.3M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Why is VISIUM TECHNOLOGIES INC's debt-to-equity ratio negative or not reported?
VISIUM TECHNOLOGIES INC (VISM) has negative shareholder equity of -$5.8M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.